Cargando…
Niacin Ameliorates Neuro-Inflammation in Parkinson’s Disease via GPR109A
In this study, we used macrophage RAW264.7 cells to elucidate the molecular mechanism underlying the anti-inflammatory actions of niacin. Anti-inflammatory actions of niacin and a possible role of its receptor GPR109A have been studied previously. However, the precise molecular mechanism of niacin’s...
Autores principales: | Giri, Banabihari, Belanger, Kasey, Seamon, Marissa, Bradley, Eric, Purohit, Sharad, Chong, Raymond, Morgan, John C., Baban, Babak, Wakade, Chandramohan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770365/ https://www.ncbi.nlm.nih.gov/pubmed/31540057 http://dx.doi.org/10.3390/ijms20184559 |
Ejemplares similares
-
Niacin Enhancement for Parkinson’s Disease: An Effectiveness Trial
por: Chong, Raymond, et al.
Publicado: (2021) -
Low-Dose Niacin Supplementation Improves Motor Function in US Veterans with Parkinson’s Disease: A Single-Center, Randomized, Placebo-Controlled Trial
por: Wakade, Chandramohan, et al.
Publicado: (2021) -
Low-dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson’s disease symptoms without side effects
por: Wakade, Chandramohan, et al.
Publicado: (2015) -
Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson’s Disease
por: Karunaratne, Tennekoon B., et al.
Publicado: (2020) -
Upregulation of GPR109A in Parkinson’s Disease
por: Wakade, Chandramohan, et al.
Publicado: (2014)